Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis

Brain Research

Volumn 1207, Issue , 2008, Pages 237-243

  Liu, Xinjie ^a   Han, Qizheng ^b   Sun, Ruopeng ^a   Li, Zhaoxia ^c  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Bacterial meningitis; Dexamethasone; Matrix metalloproteinases

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MENINGITIS; BRAIN EDEMA; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFECT; EXTRAVASATION; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MENINGITIS, PNEUMOCOCCAL; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; BACTERIA (MICROORGANISMS); RATTUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 41949132711     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.01.106     Document Type: Article

References (27)

1. Anthony D.C., Miller K.M., Fearn S., Townsend M.J., Opdenakker G., Wells G.M., Clements J.M., Chandler S., Gearing A.J., and Perry V.H. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J. Neuroimmunol 87 (1998) 62-72
2. Chanlder S., Miller K.M., Clements J.M., et al. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. [Review]. J. Neuroimmunol. 72 (1997) 155-161
3. Clements J.M., Cossins J.A., Wells G.M., Corkill D.J., Helfrich K., Wood L.M., et al. Matrix metalloproteinases expression during experimental autoimmune encephalomyelitis and effects of a combined Matrix metalloproteinase and tumor necrosis factor-alpha inhibitor. J. Neuroimmunol. 74 (1997) 85-94
4. Diab A., Zhu J., Lindquist L., et al. Haemophilus influenzae and Streptococcus pneumoniae induce different intracerebral mRNA cytokine patterns during the course of experimental bacterial meningitis. Clin. Exp. Immunol. 109 (1997) 233-241
5. Durand M.I., Calderwood S.B., Weber D.J., et al. Acute bacterial meningitis in adults: a review of 493 episodes. N. Engl. J. Med. 328 (1993) 21-28
6. Franco S.M., Cornelius V.E., and Andrews B.F. Long-term outcome of neonatal meningitis. Am. J. Dis. Child. 61 (1992) 4835-4841
7. Granert C., Raud J., Waage A., et al. Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit. Infect. Immun. 67 (1999) 2071-2074
8. Grimwood K., Nolan T.M., Bond L., Anderson V.A., Catroppa C., and Keir E.H. Risk factors for adverse outcomes of bacterial meningitis. J. Paediatr. Child Health 32 (1996) 457-462
9. Harkness K.A., Adasmson P., Sussman J.D., et al. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 123 (2000) 698-709
10. Kieseier B.C., Paul R., Koedel U., Seifert T., Clements J.M., Gearing A.J., et al. Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 122 (1999) 1579-1587
11. Kolb S.A., Lahrtz F., Paul R., Leppert D., Nadal D., Pfister H.W., and Fontana A. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J. Neuroimmunol. 84 (1998) 143-150
12. Leib S.L., and Tauber M.G. Pathogenesis of bacterial meningitis. Infect Dis. Clin. North Am. 13 (1999) 527-548
13. Leib S.L., Leppert D., Clements J., and Tauber M.G. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect. Immun. 68 (2000) 615-620
14. Leib S.L., Clements J.M., Lindberg R.L., et al. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 124 (2001) 1734-1742
15. Leppert D., Leib S.L., Grygar C., Miller K.M., Schaad U.B., and Hollander G.A. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis 31 (2000) 80-84
16. Maskos K., Fernandez-Catalan C., Huber R., et al. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3408-3412
17. McCracken G.H.J., and Saez-Llorens X. Contribution of cytokines to meningeal inflammation in bacterial meningitis. In: Peterson P.K., and Remington J.S. (Eds). In Defense of the Brain (1997), Blackwell Science, Malden, Mass 107-123
18. McIntyre P.B., Berkey C.S., King S.M., Schaad U.B., Kilpi T., Kanra G.Y., and Perez C.M. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 278 (1997) 925-931
19. Meli D.N., Loeffler J.M., Baumann P., Neumann U., Buhl T., Leppert D., and Leib S.L. In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-alpha converting enzyme attenuates seizures and injury of the cerebral cortex. J. Neuroimmunol. 151 (2004) 6-11
20. Meli D.N., Coimbra R.S., Erhart D.G., Loquet G., Bellac C.L., Tauber M.G., et al. Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect. Immun. 74 7 (2006) 3890-3896
21. Paul R., Lorenzl S., Koedel U., Sporer B., Vogel U., Frosch M., and Pfister H.W. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann. Neurol. 44 (1998) 592-600
22. Rappaport J.M., Bhatt S.M., Burkard R.F., et al. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac. J. Infect. Dis. 179 (1999) 264-268
23. Rosenberg G.A., Estrada E.Y., Dencoff J.E., and Stetler-Stevenson W.G. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res. 703 (1995) 151-155
24. Rosenberg G.A., Dencoff J.E., Correa Jr. N., et al. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 46 (1996) 1626-1632
25. Tunkel A.R., and Scheld W.M. Pathogenesis and pathophysiology of bacterial meningitis. Clin. Microbiol. Rev. 6 (1993) 118-136
26. Velasco S., Tarlow M., Olsen K., et al. Temperature-dependent modulation of lipopolysaccharide-induced interleukin-1 beta and tumor necrosis factor alpha expression in cultured human astroglial cells by dexamethasone and indomethacin. J. Clin. Invest. 87 (1991) 1674-1680
27. Xu J., Kim G.M., Ahmed S.H., Xu J., Yan P., Xu X.M., and Hsu C.Y. Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J. Neurosci. 21 1 (2001) 92-97 Jan 1